Trial Profile
A Phase 3 Multicenter, Randomized, Double-Masked Study of the Safety and Efficacy of Difluprednate 0.05% Ophthalmic Emulsion Compared to Prednisolone Acetate 1% Ophthalmic Suspension in the Treatment of Endogenous Anterior Uveitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Jan 2020
Price :
$35
*
At a glance
- Drugs Difluprednate (Primary) ; Prednisolone acetate
- Indications Anterior uveitis
- Focus Therapeutic Use
- Sponsors Alcon
- 23 Dec 2014 New trial record